The document concludes that a new biosensor can efficiently detect prostatecancer cells and that standardized referrals help find significant cancers effectively.
The conversation discusses using ketoconazole, an anti-androgen, for hair loss and whether mesotherapy with dermarolling could enhance its absorption into the scalp. The user questions if the typical 2% ketoconazole shampoo dose would be effective when used after dermarolling to target androgen receptors in the scalp.
The conversation discusses using finasteride topically for hair loss and concerns about potential side effects like feminization and impact on muscle growth. One person shared their experience with finasteride, indicating it increased testosterone and did not prevent them from gaining muscle or strength.
A dermatologist advised a patient to stop taking finasteride (fin) after turning 40 due to potential risk of aggressive prostatecancer. The patient and others in the conversation debated this advice, discussing the relationship between finasteride, prostatecancer, and hair loss, and considering alternatives like topical finasteride.
SCUBE3 is available online but poses risks like tumor promotion and high costs. Users advise against using it due to health concerns and inefficacy as a standalone treatment.
Hair loss discussion includes treatments Minoxidil, Finasteride, and RU58841. Prolactin's role in immune system's antitumor activity raises safety concerns for HMI-115.